A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia

J Antimicrob Chemother. 2013 Nov;68(11):2691-3. doi: 10.1093/jac/dkt217. Epub 2013 Jun 7.
No abstract available

Keywords: CABP; Streptococcus pneumoniae; respiratory pathogens.

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteria / classification
  • Bacteria / isolation & purification
  • Community-Acquired Infections / drug therapy*
  • Female
  • Fluoroquinolones / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Bacterial / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • 7-(3-(2-amino-1-fluoroethylidene)-1-piperidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
  • Anti-Bacterial Agents
  • Fluoroquinolones